15-74023084-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_033238.3(PML):c.859G>A(p.Val287Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,602,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_033238.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PML | NM_033238.3 | c.859G>A | p.Val287Ile | missense_variant | 3/9 | ENST00000268058.8 | NP_150241.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PML | ENST00000268058.8 | c.859G>A | p.Val287Ile | missense_variant | 3/9 | 1 | NM_033238.3 | ENSP00000268058.3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000870 AC: 2AN: 229808Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 127132
GnomAD4 exome AF: 0.00000965 AC: 14AN: 1450598Hom.: 0 Cov.: 33 AF XY: 0.00000693 AC XY: 5AN XY: 721912
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74396
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 12, 2024 | The c.859G>A (p.V287I) alteration is located in exon 3 (coding exon 3) of the PML gene. This alteration results from a G to A substitution at nucleotide position 859, causing the valine (V) at amino acid position 287 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at